A phase 3 clinical trial has shown that adding a targeted immunotherapy drug to chemotherapy dramatically improved – almost ...

The antibody drug conjugate was approved for patients with unresectable or metastatic HER2-low or -ultralow breast cancer ...

The FDA has approved a new treatment for patients with a common form of breast cancer that has spread to other parts of the ...

Why the once-stigmatized treatment is back for women under 60.

On January 17, 2025, the Food and Drug Administration (FDA) approved datopotamab deruxtecan-dlnk a Trop-2-directed antibody ...

Approval of Enhertu marks the first HER2-directed therapy indicated for adults with unresectable or metastatic HR-positive, ...

Breast cancer is more common after menopause than many realise, and understanding the risks, treatment options, and ...

Maintaining treatment with CDK4/6 inhibitors significantly suppresses the growth of breast cancer cells, even after drug resistance has developed, according to new research.

French lawmakers have voted unanimously to ensure breast cancer patients no longer have to pay out of pocket for the ...

Learn vital breast cancer warning signs and early detection methods as statistics show increasing mortality rates among Black ...

Jan. 22, 2025 — Despite significant therapeutic advances, breast cancer remains a leading cause of cancer-related death in women. Treatment typically involves surgery and follow-up hormone ...